Authors
Latest:
Innovative Contracting Solutions in a Changing Healthcare LandscapePharmaceutical and biopharmaceutical manufacturers must start thinking about new ways to navigate the evolving healthcare marketplace while continuing to deliver life-changing therapies to patients and responding to the demands of an increasingly informed and sophisticated customer base.
Latest:
Understanding Fluidized-Bed GranulationThis study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.
Latest:
How to Give Pharma’s Culture a Collaborative Shot in the ArmEveryone talks about “open innovation,” but without the right working culture it won’t succeed. MeetingZone’s Anthony Prior explains how unified communications can help kick-start the necessary change.
Latest:
Addressing Segregation of a Low-Dosage Direct BlendThe authors modified equipment and the manufacturing process to re-establish content uniformity among tablets.
Latest:
Identifying Causes Of DelaminationDelamination of glass packaging is a source of particulates in parenteral drugs, but identifying the root cause allowed the design of an improved manufacturing process for glass vials.
Latest:
Identifying Causes Of DelaminationDelamination of glass packaging is a source of particulates in parenteral drugs, but identifying the root cause allowed the design of an improved manufacturing process for glass vials.
Latest:
Identifying Causes Of DelaminationDelamination of glass packaging is a source of particulates in parenteral drugs, but identifying the root cause allowed the design of an improved manufacturing process for glass vials.
Latest:
Outsourcing Formulation Development for High-Potency CompoundsThe author lists five key areas to consider when selecting a CDMO to develop highly potent formulations.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest:
Controlled Release from Porous PlatformsThe authors present a method for controlling the release of therapeutics by applying a plasma polymer layer to the surface of porous materials.
Latest:
Why Training MattersInvesting in worker training is crucial to the success of a company. This article reviews the benefits of a robust training program in pharmaceutical bulk manufacturing.
Latest:
Why Training MattersInvesting in worker training is crucial to the success of a company. This article reviews the benefits of a robust training program in pharmaceutical bulk manufacturing.
Latest:
Understanding Fluidized-Bed GranulationThis study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.
Latest:
Best Practices for Color CodingPharmaceutical manufacturing facilities can help prevent contamination and cross contamination by using color coding.
Latest:
Emerging Markets—An Opportunity for Pharma to Drive Sustainable GrowthCambridge Consultants engaged in a workshop-style dialogue with a cross section of senior personnel from both Indian and multinational pharma companies to debate whether emerging markets are an opportunity to drive sustainable growth. Conclusions from the workshop are presented in this article.
Latest:
Do Pharmacopoeias Inadvertently Facilitate Data Integrity Violations?Analysts should understand how a monograph, together with the associated general notices and general chapters, relate to their responsibilities under good manufacturing practices.
Latest:
Reducing the Documentation Burden in Process ValidationThe author discusses the collection and evaluation of data part of FDA’s definition of process validation.
Latest:
Targeting Nitrosamine Precursors with Novel Active Material Science Scavenger TechnologiesWebinar Date/Time: Thu, Jun 27, 2024 11:00 AM EDT
Latest:
EMA Guideline on Setting Health-Based Exposure LimitsThe results of an industry workgroup’s examination of EMA’s guide on shared facilities are presented.
Latest:
EMA Guideline on Setting Health-Based Exposure LimitsThe results of an industry workgroup’s examination of EMA’s guide on shared facilities are presented.
